SES AI receives NYSE minimum-price deficiency notice, has six months to cure
SES AI Corporation received notice from the New York Stock Exchange on July 17, 2026 that it failed to maintain compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of its Class A common stock was less than $1.00 over a consecutive 30 trading-day period. The company has a six-month cure period and can regain compliance if the closing price reaches at least $1.00 and the 30-day average closing price is at least $1.00 on the last trading day of any calendar month during that period. The stock will continue trading on the NYSE during the cure period, subject to compliance with other listing standards.
Key facts
- NYSE notice received July 17, 2026 for Section 802.01C non-compliance
- Average closing price of Class A common stock was less than $1.00 over 30 consecutive trading days
- Six-month cure period following receipt of notice
- Company can regain compliance if closing price at least $1.00 and 30-day average at least $1.00 on last trading day of any calendar month during cure period
- Stock continues trading on NYSE during cure period
- Company must respond to NYSE within 10 business days of receipt
Why it matters
SES AI faces delisting risk if it cannot restore its stock price above the $1.00 minimum within six months, though the company retains options including a stockholder-approved reverse split to reset the price threshold.
Share
Derived from 8-K filed 2026-07-20. Not investment advice. View the source filing on SEC.gov →